Depo-Provera Lawsuit Deadline by State: 2026 Filing Guide

Last Updated: July 16, 2026 | Reviewed by: Legal Lawsuit Editorial Team | Key Sources: state statutes of limitations, JPML MDL docket records and FDA drug labeling records.

Few parts of a Depo-Provera claim matter more — or confuse people more — than the statute of limitations. Medical evidence can be strong and it won’t matter if the filing deadline has passed; a late claim can be thrown out before anyone hears it. Deadlines come from state law and hinge on when the legal clock starts, so there’s no one answer for the whole country. Below we explain how these time limits usually work, why the start date carries so much weight, and how to figure out your own deadline.

How the Depo-Provera Statute of Limitations Works in Each State

A statute of limitations is a state law capping how long you have to sue after being injured. For personal injury and product liability claims such as the Depo-Provera meningioma lawsuit, most states allow somewhere from one to six years — yet both the length of that period and the event that starts it vary considerably by state.

In some states the clock begins on the date of your first meningioma diagnosis. In others it may start when you stopped taking Depo-Provera, or when a reasonable person would have linked the injury to the drug. That’s why two people diagnosed the very same day but living in different states can have entirely different filing deadlines.

The Discovery Rule: Why It Can Extend Your Filing Window

A number of states use a “discovery rule,” which holds off the filing clock until you knew — or reasonably should have known — that Depo-Provera was tied to your meningioma. Because the FDA did not formally add the meningioma risk to the label until late 2025, this rule can be especially important for people diagnosed before that link was widely publicized.

Whether a court will apply the discovery rule, and how it fixes the starting date, depends on the specific facts. It’s a big reason a generic online estimate can’t stand in for a review of your case by an attorney licensed in your state.

Does the Federal MDL Change Your Deadline?

Federal Depo-Provera cases are grouped together in MDL 3140. Joining the MDL typically leaves your state’s statute of limitations untouched — the MDL handles shared pretrial work such as discovery and expert testimony, but each claim usually must still be filed on time under the law of the state where it arose. The U.S. Judicial Panel on Multidistrict Litigation publishes the official case count and MDL status.

How Your Filing Date Affects Settlement Value

The filing deadline is more than a technicality — it shapes how much leverage a claim has. A case filed comfortably inside the limitations period, backed by clear records of diagnosis and product use, usually negotiates from a stronger position than one rushed in at the last minute with gaps in the paperwork. For more on how Depo-Provera claims are being valued right now, read our latest Depo-Provera settlement update.

Not Sure When Your Deadline Is? Take These Steps

• Act now rather than later. Limitations questions are urgent by nature, and putting off a consultation could cost you the entire claim.
• Pull together your diagnosis records. The precise date you were diagnosed with meningioma, plus records showing when you used Depo-Provera, drive the deadline calculation.
• Get an attorney to confirm your state’s rule. Since states apply the discovery rule differently, a general timeline can’t replace advice tailored to you.
• Ask whether tolling applies. In some states, circumstances such as being a minor when injured can pause or lengthen the filing deadline.

Depo-Provera Filing Deadline FAQs

Does every state use the same Depo-Provera filing deadline? No. It usually ranges from one to six years, but the precise length and what starts the clock depend on your state’s law.

What if I don’t remember my diagnosis date? Your medical records normally pin it down, which is why collecting them early is so important.

Is it too late if several years have passed? Not necessarily — depending on your state’s discovery rule and when you reasonably linked your diagnosis to Depo-Provera, you may still have time. That calls for an individual review, not an assumption in either direction.

FDA safety information about the meningioma risk tied to medroxyprogesterone acetate (Depo-Provera) appears in the FDA-approved prescribing label; for official MDL case status, visit the U.S. Judicial Panel on Multidistrict Litigation.

This page provides general information, not legal advice. Limitations periods and the discovery rule differ by state and can change. Talk with a licensed attorney about your particular deadline.